S&P 500   5,051.41
DOW   37,798.97
QQQ   431.10
ASML’s Earnings Could Bring The Stock to New Highs
Kinder Morgan Stock Bid Up In An Oil Breakout
Undervalued UnitedHealth Group Won’t Be For Long
Silicon Motion Proves That AI in Motion Stays in Motion
DocuSign and The Case for 66% Upside 
3 Computer Vision Stocks for Long-Term Gains From AI
Closing prices for crude oil, gold and other commodities
S&P 500   5,051.41
DOW   37,798.97
QQQ   431.10
ASML’s Earnings Could Bring The Stock to New Highs
Kinder Morgan Stock Bid Up In An Oil Breakout
Undervalued UnitedHealth Group Won’t Be For Long
Silicon Motion Proves That AI in Motion Stays in Motion
DocuSign and The Case for 66% Upside 
3 Computer Vision Stocks for Long-Term Gains From AI
Closing prices for crude oil, gold and other commodities
S&P 500   5,051.41
DOW   37,798.97
QQQ   431.10
ASML’s Earnings Could Bring The Stock to New Highs
Kinder Morgan Stock Bid Up In An Oil Breakout
Undervalued UnitedHealth Group Won’t Be For Long
Silicon Motion Proves That AI in Motion Stays in Motion
DocuSign and The Case for 66% Upside 
3 Computer Vision Stocks for Long-Term Gains From AI
Closing prices for crude oil, gold and other commodities
S&P 500   5,051.41
DOW   37,798.97
QQQ   431.10
ASML’s Earnings Could Bring The Stock to New Highs
Kinder Morgan Stock Bid Up In An Oil Breakout
Undervalued UnitedHealth Group Won’t Be For Long
Silicon Motion Proves That AI in Motion Stays in Motion
DocuSign and The Case for 66% Upside 
3 Computer Vision Stocks for Long-Term Gains From AI
Closing prices for crude oil, gold and other commodities

Cogent Biosciences (COGT) SEC Filings & 10K Form

$6.46
-0.04 (-0.62%)
(As of 04/16/2024 ET)

Recent Cogent Biosciences SEC Filings

DateFilerForm TypeView
04/02/2024
3:21 PM
Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/18/2024
4:18 PM
Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/14/2024
5:01 PM
Conlin Matthew (Reporting)
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/14/2024
4:57 PM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Schulke Ryan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024
5:16 PM
Conlin Matthew (Reporting)
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024
5:17 PM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Schulke Ryan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024
5:26 PM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Perfit Ryan MacNab (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
8:43 PM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Schulke Ryan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
8:40 PM
Conlin Matthew (Reporting)
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2024
4:41 PM
Conlin Matthew (Reporting)
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2024
4:43 PM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Schulke Ryan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
5:23 PM
Conlin Matthew (Reporting)
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
5:24 PM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Patrick Donald Huntley (Reporting)
Form 4/A
03/06/2024
5:25 PM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Schulke Ryan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
5:25 PM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Perfit Ryan MacNab (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
11:05 AM
Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/13/2024
4:51 PM
Cogent Biosciences (Subject)
Fluent, Inc. (Subject)
JB CAPITAL PARTNERS LP (Filed by)
Form SC 13G/A
02/12/2024
3:54 PM
Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
Form DEF 14A
02/08/2024
9:30 AM
Cogent Biosciences (Subject)
Fluent, Inc. (Subject)
WELLINGTON TRUST Co N A (Filed by)
Form SC 13G/A
02/01/2024
3:50 PM
Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
Form PRE 14A
01/19/2024
3:36 PM
Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/29/2023
2:32 PM
Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/28/2023
3:05 PM
Cogent Biosciences (Subject)
Fluent, Inc. (Subject)
GLOBAL VALUE INVESTMENT CORP. (Filed by)
Form SC 13D/A
12/18/2023
4:57 PM
Conlin Matthew (Reporting)
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2023
4:58 PM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Schulke Ryan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/14/2023
9:23 AM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Schulke Ryan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/14/2023
9:28 AM
Conlin Matthew (Reporting)
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2023
10:21 AM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Patrick Donald Huntley (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2023
8:54 AM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Schulke Ryan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2023
8:57 AM
Conlin Matthew (Reporting)
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/08/2023
1:50 PM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Schulke Ryan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/07/2023
7:44 AM
Conlin Matthew (Reporting)
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/07/2023
7:46 AM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Perfit Ryan MacNab (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2023
5:13 PM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Schulke Ryan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2023
3:46 PM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Schulke Ryan (Reporting)
Form 4/A
11/30/2023
7:59 PM
Conlin Matthew (Reporting)
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/30/2023
8:01 PM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Schulke Ryan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2023
5:32 PM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Schulke Ryan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2023
5:25 PM
Conlin Matthew (Reporting)
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2023
8:23 PM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Schulke Ryan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2023
8:28 PM
Conlin Matthew (Reporting)
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
Could Bitcoin Literally FORCE This Crypto To Rocket Up? (Ad)

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

>>Click here to find out what it is.
11/15/2023
3:48 PM
Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
Form NT 10-Q
11/15/2023
3:50 PM
Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/31/2023
3:42 PM
Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/17/2023
4:24 PM
Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/25/2023
3:34 PM
Cogent Biosciences (Subject)
Fluent, Inc. (Subject)
FROST PHILLIP MD ET AL (Filed by)
Form SC 13D/A
09/21/2023
3:44 PM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Frost Gamma Investments Trust (Reporting)
FROST PHILLIP MD ET AL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2023
4:26 PM
Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
Form NT 10-Q
07/18/2023
4:29 PM
Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/26/2023
10:29 AM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Patrick Donald Huntley (Reporting)
Form 4/A
06/15/2023
10:21 AM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Graff David Allen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2023
8:53 PM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
SHATTUCK KOHN BARBARA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2023
8:55 PM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Mathis Donald H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2023
8:58 PM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
PFENNIGER RICHARD C JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2023
8:51 PM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
NEWELL CARLA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2023
9:01 AM
Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/30/2023
6:36 PM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Schulke Ryan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2023
6:37 PM
Conlin Matthew (Reporting)
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Form 4/A
05/30/2023
6:40 PM
Conlin Matthew (Reporting)
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/26/2023
1:30 PM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Perfit Ryan MacNab (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/26/2023
1:34 PM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Perfit Ryan MacNab (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2023
12:24 PM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Schulke Ryan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2023
6:27 PM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Patrick Donald Huntley (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2023
1:31 PM
Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/05/2023
3:15 PM
Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/01/2023
3:40 PM
Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
Form DEF 14A
05/01/2023
3:41 PM
Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
Form ARS
04/28/2023
2:46 PM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Patrick Donald Huntley (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:COGT) was last updated on 4/17/2024 by MarketBeat.com Staff

From Our Partners